IGENICA BIOTHERAPEUTICS, INC

Profile

Company Names

IGENICA BIOTHERAPEUTICS, INC
IGENICA INC

Addresses

863A MITTEN RD., SUITE 100B, BURLINGAME, CA 94040

863 MITTEN RD., SUITE 102, BURLINGAME, CA 94010

849 MITTEN RD., SUITE 104, BURLINGAME, CA 94010

Phone Numbers

(650) 231-4320
(650) 697-4900

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2008

State Incorporated:

DELAWARE

Total Amount Raised:

$51,947,069.00

Number of Funding Rounds:

10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2015-09-29 
$2,250,001.00 
$5,000,000.00 
$2,749,999.00 
Equity 
9
2015-05-22 
$1,233,334.00 
$4,000,000.00 
$2,766,666.00 
Equity 
8
2015-01-08 
$5,051,844.00 
$6,250,000.00 
$1,198,156.00 
Equity 
7
2014-01-23 
$7,033,558.00 
$14,067,117.00 
$7,033,559.00 
Equity 
6
2012-09-14 
$0.00 
$16,800.00 
$16,800.00 
 
5
2012-06-08 
$20,295,000.00 
$33,325,000.00 
$13,030,000.00 
Equity 
4
2012-04-17 
$0.00 
$42,000.00 
$42,000.00 
 
3
2010-08-11 
$0.00 
$72,000.00 
$72,000.00 
 
2
2010-04-20 
$16,083,332.00 
$24,125,000.00 
$8,041,668.00 
Equity 
1
2009-07-02 
$0.00 
$22,500.00 
$22,500.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LUIS 
 
BAYOL 
EXECUTIVE OFFICER
JOHN 
 
CELEBI 
EXECUTIVE OFFICER
GUOQING 
 
CHEN 
EXECUTIVE OFFICER
GWEN 
 
FYFE 
DIRECTOR
GWEN 
A. 
FYFE 
DIRECTOR
MARK 
 
GOLDSMITH 
DIRECTOR
MARK 
A. 
GOLDSMITH 
DIRECTOR
MARY 
 
HAAK-FRENDSCHO 
EXECUTIVE OFFICER, DIRECTOR
MIKE 
 
ROTHE 
EXECUTIVE OFFICER, DIRECTOR
ROBERT 
 
SCHREIBER 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-29 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-05-22 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-01-08 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-01-23 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-06-08 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2012-09-14 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-06-08 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2012-04-17 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-20 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2010-08-11 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-20 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2009-07-02 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#